Mehmet Akce

Academic / Other · 2 registered clinical trials — 2 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Loc Combined Hepatocellular and Cholangiocarcinoma	Phase 2	2026-05-01
Recruiting	A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Intrahepatic Cholangiocarcinoma, FGFR2 Gene Rearrangement, FGFR2 Gene Mutation	Phase 2	2026-01-27